People are curious if it will be more effective than current treatments like semaglutide and tirzepatide
A handful of glucagon-like peptide-1 (GLP-1) agonists have received US Food and Drug Administration (FDA) approval for obesity treatmentincluding liraglutide (Saxenda), semaglutide (Wegovy), and tirzepatide (Zepbound)while others, like exenatide (Byetta, Bydureon), liraglutide (Victoza), semaglutide (Ozempic, Rybelsus), and tirzepatide (again, known as Mounjaro for the diabetes indication), are indicated for type 2 diabetes
Hormones, insulin resistance, medications, and stress all play a role
It has been determined that inflammation has been identified as a severe risk factor for the development of cardiovascular diseases [56]
Holly Lofton at NYU pointed out that skipping brand-name safety frameworks can leave patients exposed to unnecessary risks